Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Pyridoxine-Dependent Epilepsy With Poor Neurodevelopmental Outcome: Case Report
Avantika Chauhan1, Shalini Tripathi2, Mala Kumar3
1Senior Resident, Department of Pediatrics, King George's Medical University, Lucknow, Uttar Pradesh, India.
Pyridoxine-dependent seizures, a rare neonatal condition, often resist standard treatments but respond to pyridoxine. Genetic analysis identified an ALDH7A1 mutation in a case with intractable seizures and metabolic issues.
Area of Science:
- Medical Genetics
- Neonatology
- Biochemistry
Background:
- Pyridoxine-dependent seizures (PDs) are a rare, severe epilepsy syndrome in newborns.
- These seizures are typically refractory to conventional antiepileptic drugs.
- Diagnosis can be challenging due to varied clinical presentations and lack of specific biomarkers.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Inborn Errors of Metabolism
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

